Evidence map›Paper›PMID 38132820›Full record

ArticleJournal of functional biomaterials2023

Photochemical Modification of the Extracellular Matrix to Alter the Vascular Remodeling Process.

Blake Anderson, Dylan Blair, Kenji Huff, John Wisniewski, Kevin S Warner, Katalin Kauser

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Blake AndersonBiology Department, Alucent Biomedical Inc., Salt Lake City, UT 84108, USA.
Dylan BlairEngineering Department, Alucent Biomedical Inc., Salt Lake City, UT 84108, USA.
Kenji HuffEngineering Department, Alucent Biomedical Inc., Salt Lake City, UT 84108, USA.ORCID 0009-0003-1728-4505
John WisniewskiPharmaceutical Development, Alucent Biomedical Inc., Salt Lake City, UT 84108, USA.
Kevin S WarnerPharmaceutical Development, Alucent Biomedical Inc., Salt Lake City, UT 84108, USA.
Katalin KauserBiology Department, Alucent Biomedical Inc., Salt Lake City, UT 84108, USA.ORCID 0000-0001-6709-4652

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic interventions for vascular diseases aim at achieving long-term patency by controlling vascular remodeling. The extracellular matrix (ECM) of the vessel wall plays a crucial role in regulating this process. This study introduces a novel photochemical treatment known as Natural Vascular Scaffolding, utilizing a 4-amino substituted 1,8-naphthimide (10-8-10 Dimer) and 450 nm light. This treatment induces structural changes in the ECM by forming covalent bonds between amino acids in ECM fibers without harming vascular cell survival, as evidenced by our results. To further investigate the mechanism of this treatment, porcine carotid artery segments were exposed to 10-8-10 Dimer and light activation. Subsequent experiments subjected these segments to enzymatic degradation through elastase or collagenase treatment and were analyzed using digital image analysis software (MIPAR) after histological processing. The results demonstrated significant preservation of collagen and elastin structures in the photochemically treated vascular wall, compared to controls. This suggests that photochemical treatment can effectively modulate vascular remodeling by enhancing the resistance of the ECM scaffold to degradation. This approach shows promise in scenarios where vascular segments experience significant hemodynamic fluctuations as it reinforces vascular wall integrity and preserves lumen patency. This can be valuable in treating veins prior to fistula creation and grafting or managing arterial aneurysm expansion.

Indexed as

bio-scaffoldextracellular matrixnatural vascular scaffoldingphotosensitized protein crosslinkingtissue remodelingvascular diseasevascular remodeling

Identifiers

PMID38132820
PMCPMC10744111
OpenAlexW4389782955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.